🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought itRead More

Novavax Inc (NVAX)

NASDAQ
Currency in USD
Disclaimer
15.669
-2.501(-13.77%)
Real-time Data

NVAX Comments

short-term shoulder head shoulder pattern
just bought 16.26 hopefully reversal today
short to 15
Well, it appears to be testing a support level around 17.45 - 17.39
Hunt then scam more ignorant bears it seem, friends
Today it looked like a sticker shock movement. I didn't look a bear case. Let's see tomorrow.
big volume today, shorting started
he's a stupid communist
he's a stupid communist
see today
it will go once more time to 100 dollar
see the diagram mate since 1998 and see how many times has 100 dollar so then was probably COVID 1,2,3,4 and etc it just needs 1 or 2 good more reports
No way to reach 100, the best-case scenario is before November 75 to 80
I'm not taking about time I'm talking about on next month's or till next year it needs just a new vaccine with combination of flu and COVID or malaria vaccine to go there
go to the moooooon
Before $30, 26.0 Awaiting
I agree soon again on 100
140$
Bears have no money and shame, friends
It hurts a lot
Next level 30
you are Shure?
I hurts a lotttt
opened new position on Pfizer 1000 calls on January 2025 strike 30
but my covered calls preventing to make more money. may should close position tomorrow
so we close above 16.25 which is become support now. if staying tomorrow above this level its a buy. as you can see my previous post I bought 9.4 and 13.44 total 28 thousand shares . life is good
buy and hold
Thoughts?
unsuccessful attempt to clear resistance 16.25 yesterday . let's see how it will play out
Think alot of people will buy nvax today due to autocorrect when they type in nvda
AHAHAHAH never thought about it
if clear that resistance and stay 2 day above 16.25 level next around 20
look on the chart was supported there then it become resistance. look back you'll see
20 is also resistance??
let's see 16.25 1st
16.25 resistance so if you have naked position be aware. I have covered call long 26000 of stock short 260 contract call 15 June but
Serum Institute deploys first doses of Oxford, Novavax-partnered malaria shot to Africa In 2022, Africa was home to 94% of all malaria cases (233 million) and 95% (580,000) of malaria deaths, according to WHO. Children under 5 accounted for about 80% of malaria deaths on the continent that year. https://www.fiercepharma.com/pharma/serum-institute-deploys-first-doses-oxford-novavax-partnered-malaria-shot-africa
Thank you Aiken good new
Bears should have no money and shame at 420.69 soon, friends
...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.